One in five patients referred for vascular access surgery experience an unsustainable treatment burden, with poor health ...

In 2019, a meta-analysis suggested that the risk of coronary morbidity was 30% higher among Sjögren's patients than it was ...

The PAD Collaborative, a group of 17 organizations convened by the American Heart Association to address the growing burden ...

Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

University of Virginia School of Medicine scientists have obtained important new insights into how our bodies regulate our ...

EADaily, December 7th, 2025. The traditional treatment of hypertension can be radically revised. This is evidenced by recent ...

The Family Heart Foundation, a leading research and advocacy organization, published new research in the American Journal of ...

Angiogenesis inhibitors showed no increased risk of arterial dissections or aneurysms in metastatic colorectal cancer patients. The study involved 34,733 patients, with 195 cases matched to 1950 ...

Spurred by a positive clinical trial readout recently, Xeltis has raised €47.5m ($55.1m) to advance commercialisation efforts ...

Approximately 80% of cardiovascular disease is preventable through lifestyle modifications and risk factor management, according to the American Heart Association’s “Life's Essential Eight” framework, ...

Scientists at Northwell Health's Feinstein Institutes for Medical Research have uncovered a critical mechanism driving vascular cognitive impairment (VCI), the world's second most common form of ...

Alzheimer's disease is one of the main causes of dementia. Currently, there are a limited number of treatments available, ...